AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/110

Authors: Sunder-Plassmann, G Horl, WH
Citation: G. Sunder-plassmann et Wh. Horl, The clinical potential of novel erythropoiesis stimulating protein, EXPERT OP B, 1(4), 2001, pp. 733-739

Authors: Schmaldienst, S Mullner, M Goldammer, A Spitzauer, S Banyai, S Horl, WH Derfler, K
Citation: S. Schmaldienst et al., Intravenous immunoglobulin application following immunoadsorption: benefitor risk in patients with autoimmune diseases?, RHEUMATOLOG, 40(5), 2001, pp. 513-521

Authors: Cohen, G Rudnicki, M Walter, F Niwa, T Horl, WH
Citation: G. Cohen et al., Glucose-modified proteins modulate essential functions and apoptosis of polymorphonuclear leukocytes, J AM S NEPH, 12(6), 2001, pp. 1264-1271

Authors: Bohmig, GA Regele, H Exner, M Derhartunian, V Kletzmayr, J Saemann, MD Horl, WH Druml, W Watschinger, B
Citation: Ga. Bohmig et al., C4d-positive acute humoral renal allograft rejection: Effective treatment by immunoadsorption, J AM S NEPH, 12(11), 2001, pp. 2482-2489

Authors: Tarng, DC Yang, JC Huang, TP Sunder-Plassmann, G Horl, WH
Citation: Dc. Tarng et al., The Eighth Asian-Pacific Congress of Nephrology - 26-30 March 2000 - Taipei, Taiwan - Foreword, NEPH DIAL T, 16, 2001, pp. 1-1

Authors: Sunder-Plassmann, G Horl, WH
Citation: G. Sunder-plassmann et Wh. Horl, Novel aspects of erythropoietin response in renal failure patients, NEPH DIAL T, 16, 2001, pp. 40-44

Authors: Aljama, P Bommer, J Canaud, B Carrera, F Eckardt, KU Horl, WH Kredict, RT Locatelli, F Macdougall, IC Wikstrom, B
Citation: P. Aljama et al., Practical guidelines for the use of NESP in treating renal anaemia, NEPH DIAL T, 16, 2001, pp. 22-28

Authors: Horl, WH
Citation: Wh. Horl, Intraplatelet calcium levels in patients with acute renal failure, NEPH DIAL T, 16(11), 2001, pp. 2275-2276

Authors: Regele, H Exner, M Watschinger, B Wenter, C Wahrmann, M Osterreicher, C Saemann, MD Mersich, N Horl, WH Zlabinger, GJ Bohmig, GA
Citation: H. Regele et al., Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection, NEPH DIAL T, 16(10), 2001, pp. 2058-2066

Authors: Horl, WH
Citation: Wh. Horl, Professor Bruno Watschinger, NEPH DIAL T, 16(1), 2001, pp. 184-184

Authors: Apsner, R Muhm, M Unver, B Horl, WH Sunder-Plassmann, G
Citation: R. Apsner et al., Expanding our interventional skills: Placement of totally implantable injection ports by internists/intensivists, ACT MED AUS, 28(1), 2001, pp. 23-26

Authors: Horl, WH
Citation: Wh. Horl, Are new toxins appearing on the horizon?, CONTR NEPHR, 133, 2001, pp. 28-41

Authors: Sunder-Plassmann, G Horl, WH
Citation: G. Sunder-plassmann et Wh. Horl, Novel Erythropoiesis Stimulating Protein (NESP), NIEREN HOCH, 30(4), 2001, pp. 166-173

Authors: Deicher, R Horl, WH
Citation: R. Deicher et Wh. Horl, Renal osteodystrophy: new approaches to therapy with calcitriol, analogs and calcimimetics, NIEREN HOCH, 30(2), 2001, pp. 59-66

Authors: Feix, A Fritsche-Polanz, R Kletzmayr, J Vychytil, A Horl, WH Sunder-Plassmann, G Fodinger, M
Citation: A. Feix et al., Increased prevalence of combined MTR and MTHFR genotypes among individualswith severely elevated total homocysteine plasma levels, AM J KIDNEY, 38(5), 2001, pp. 956-964

Authors: Apsner, R Buchmayer, H Lang, T Unver, B Speiser, W Sunder-Plassmann, G Horl, WH
Citation: R. Apsner et al., Simplified citrate anticoagulation for high-flux hemodialysis, AM J KIDNEY, 38(5), 2001, pp. 979-987

Authors: Sunder-Plassmann, G Horl, WH
Citation: G. Sunder-plassmann et Wh. Horl, Effect of erythropoietin on cardiovascular diseases, AM J KIDNEY, 38(4), 2001, pp. S20-S25

Authors: Fodinger, M Buchmayer, H Heinz, G Papagiannopoulos, M Kletzmayr, J Perschl, A Vychytil, A Horl, WH Sunder-Plassmann, G
Citation: M. Fodinger et al., Association of two MTHFR polymorphisms with total homocysteine plasma levels in dialysis patients, AM J KIDNEY, 38(1), 2001, pp. 77-84

Authors: Lilaj, T Dittrich, E Puttinger, H Schneider, B Haag-Weber, M Horl, WH Vychytil, A
Citation: T. Lilaj et al., A preceding exchange with polyglucose versus glucose solution modifies peritoneal equilibration test results, AM J KIDNEY, 38(1), 2001, pp. 118-126

Authors: Kramer, L Horl, WH
Citation: L. Kramer et Wh. Horl, Biocompatibility of sorbent suspension dialysis in cirrhotic patients withhepatic encephalopathy - In reply, AM J KIDNEY, 38(1), 2001, pp. 220-220

Authors: Hauser, AC Hagen, W Rehak, PH Buchmayer, H Fodinger, M Papagiannopoulos, M Bieglmayer, C Apsner, R Koller, E Ignatescu, M Horl, WH Sunder-Plassmann, G
Citation: Ac. Hauser et al., Efficacy of folinic versus folic acid for the correction of hyperhomocysteinemia in hemodialysis patients, AM J KIDNEY, 37(4), 2001, pp. 758-765

Authors: Horl, WH
Citation: Wh. Horl, Should we still use iron dextran in hemodialysis patients?, AM J KIDNEY, 37(4), 2001, pp. 859-861

Authors: Lorenz, M Regele, H Kovarik, J Horl, WH Klauser, R
Citation: M. Lorenz et al., Rapidly progressive glomerulonephritis and carcinoma of the hypopharynx, AM J KIDNEY, 37(1), 2001, pp. NIL_81-NIL_84

Authors: Konner, P Watschinger, B Apfalter, P Horl, WH Vychytil, A
Citation: P. Konner et al., A case of continuous ambulatory peritoneal dialysis peritonitis with an uncommon organism and an atypical clinical course, AM J KIDNEY, 37(1), 2001, pp. NIL_107-NIL_110

Authors: Franz, M Woloszczuk, W Horl, WH
Citation: M. Franz et al., Adsorption of natriuretic factors in uremia, SEM NEPHROL, 21(3), 2001, pp. 298-302
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>